We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

22 hedge funds and large institutions have $4.2M invested in Cumberland Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more funds holding

Funds holding: 17 → 22 (+5)

3.76% less ownership

Funds ownership: 16.69% → 12.93% (-3.8%)

29% less capital invested

Capital invested by funds: $5.89M → $4.2M (-$1.69M)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
22
Holders Change
+5
Holders Change %
+29.41%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
6
Closed
–
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$67.6K
2
Millennium Management
Millennium Management
New York
+$47.3K
3
Prudential Financial
Prudential Financial
New Jersey
+$10.7K
4
UBS Group
UBS Group
Switzerland
+$8.64K
5
BlackRock
BlackRock
New York
+$626

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$34.6K
2
Two Sigma Investments
Two Sigma Investments
New York
-$15.7K
3
Morgan Stanley
Morgan Stanley
New York
-$3.76K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$464
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$313

CPIX Hedge Fund Activity: Q4 2022 in Review

22 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2022, worth a combined $4.2M — down 29% from $5.89M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CPIX positions and 0 closed out — a net gain of 6 holders — while 3 added to existing stakes and 6 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $67.6K. The largest seller was Renaissance Technologies, cutting an estimated $34.6K.

  • 22 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2022, up from 17 in Q3 2022.
  • Funds reported $4.2M of Cumberland Pharmaceuticals stock for Q4 2022, down 29% quarter-over-quarter.
  • 6 funds opened new Cumberland Pharmaceuticals positions in Q4 2022 and 0 closed out, a net change of +6 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2022 was Citadel Advisors, an estimated $67.6K added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2022 was Renaissance Technologies, an estimated $34.6K sold.

Based on aggregated 13F filings for Q4 2022.